Regents Of The University Of California Buys DoorDash Inc, Alibaba Group Holding, Palantir Technologies Inc, Sells Allogene Therapeutics Inc, Revolution Medicines Inc, Orchard Therapeutics PLC

• New Purchases: DASH, PLTR, EB, CTMX, BLI, CWT,
• Added Positions: BABA,
• Reduced Positions: ALLO, CNST, RAPT,
• Sold Out: RVMD, ORTX, MMC,

For the details of REGENTS OF THE UNIVERSITY OF CALIFORNIA's stock buys and sells, go to https://www.gurufocus.com/guru/regents+of+the+university+of+california/current-portfolio/portfolio

1. Owl Rock Capital Corp (ORCC) - 42,690,843 shares, 77.05% of the total portfolio.
2. Alibaba Group Holding Ltd (BABA) - 221,026 shares, 6.57% of the total portfolio. Shares added by 24.82%
3. Allogene Therapeutics Inc (ALLO) - 675,743 shares, 3.13% of the total portfolio. Shares reduced by 24.93%
4. RAPT Therapeutics Inc (RAPT) - 1,000,000 shares, 2.91% of the total portfolio. Shares reduced by 10.89%
5. DoorDash Inc (DASH) - 141,841 shares, 2.44% of the total portfolio. New Position

Regents Of The University Of California initiated holding in DoorDash Inc. The purchase prices were between $125.53 and $215.16, with an estimated average price of $168.08. The stock is now traded at around $143.320000. The impact to a portfolio due to this purchase was 2.44%. The holding were 141,841 shares as of 2021-03-31.

Regents Of The University Of California initiated holding in Palantir Technologies Inc. The purchase prices were between $21.73 and $39, with an estimated average price of $27.5. The stock is now traded at around $22.630000. The impact to a portfolio due to this purchase was 0.37%. The holding were 120,049 shares as of 2021-03-31.

Regents Of The University Of California initiated holding in Eventbrite Inc. The purchase prices were between $16.35 and $25.81, with an estimated average price of $20.08. The stock is now traded at around $20.980000. The impact to a portfolio due to this purchase was 0.1%. The holding were 33,292 shares as of 2021-03-31.

Regents Of The University Of California initiated holding in CytomX Therapeutics Inc. The purchase prices were between $6.6 and $9, with an estimated average price of $7.93. The stock is now traded at around $8.530000. The impact to a portfolio due to this purchase was 0.08%. The holding were 75,000 shares as of 2021-03-31.

Regents Of The University Of California initiated holding in Berkeley Lights Inc. The purchase prices were between $44.33 and $89.26, with an estimated average price of $68.37. The stock is now traded at around $48.020000. The impact to a portfolio due to this purchase was 0.06%. The holding were 9,342 shares as of 2021-03-31.

Regents Of The University Of California initiated holding in California Water Service Group. The purchase prices were between $52.59 and $60.27, with an estimated average price of $55.48. The stock is now traded at around $61.220000. The impact to a portfolio due to this purchase was 0.03%. The holding were 3,650 shares as of 2021-03-31.

Regents Of The University Of California added to a holding in Alibaba Group Holding Ltd by 24.82%. The purchase prices were between $222.72 and $270.83, with an estimated average price of $245.98. The stock is now traded at around $229.440000. The impact to a portfolio due to this purchase was 1.31%. The holding were 221,026 shares as of 2021-03-31.

Regents Of The University Of California sold out a holding in Revolution Medicines Inc. The sale prices were between $37.21 and $54.43, with an estimated average price of $44.92.

Regents Of The University Of California sold out a holding in Orchard Therapeutics PLC. The sale prices were between $4.39 and $9.08, with an estimated average price of $7.13.

Regents Of The University Of California sold out a holding in Marsh & McLennan Companies Inc. The sale prices were between $107.6 and $121.88, with an estimated average price of $115.13.

Regents Of The University Of California reduced to a holding in Allogene Therapeutics Inc by 24.93%. The sale prices were between $25.79 and $39.02, with an estimated average price of $33.75. The stock is now traded at around $35.120000. The impact to a portfolio due to this sale was -0.82%. Regents Of The University Of California still held 675,743 shares as of 2021-03-31.